Efficacy, Safety, and Tolerability of Theta-Burst Stimulation in Mixed Depression: Design, Rationale, and Objectives of a Randomized, Double-Blinded, Sham-Controlled Trial

Imagem de Miniatura
Arquivos
art_TAVARES_Efficacy_Safety_and_Tolerability_of_ThetaBurst_Stimulation_in_2020.PDF.pdf (439.02 KB)
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2020
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
FRONTIERS MEDIA SA
Autores
Citação
FRONTIERS IN PSYCHIATRY, v.11, article ID 435, 9p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction Mixed-specifier mood disorders are probably a different subgroup in terms of response to treatment, socio-demographic parameters, course, and family history. Here we describe the rationale and design of a clinical trial aimed to test the efficacy, safety, and tolerability of a non-pharmacological treatment known as theta-burst stimulation (TBS) for treating the mixed depressive episodes of both bipolar (I or II), and unipolar depression. Methods The study is designed as a randomized, sham-controlled, double-blinded clinical trial evaluating TBS for the treatment of moderate or severe major depressive episodes with mixed features of patients receiving at least one first or second-line pharmacological treatment for depressive episodes without adequate response. Ninety adult (18 to 65 years old) patients will be enrolled and submitted to 6-week (comprising 5 consecutive days a week sessions for the first 3 weeks and then 2 days a week for a further 3 week) of inhibitory followed by excitatory TBS in dorsolateral prefrontal cortex. Participants will be assessed using clinical and neuropsychological tests before and after the intervention. The primary outcome is change in Montgomery-angstrom sberg Depression Scale (MADRS) score over time and across groups. Cognitive parameters will also be assessed with neuropsychological tests. Results The clinical results will provide evidence about TBS as an adjunctive treatment for mixed depression treatment and neuropsychological parameters will contribute toward an improved understanding the effects of TBS in cognition. Conclusion Our results could introduce a novel therapeutic technique for mixed depressive episodes of both bipolar and unipolar disorders.
Palavras-chave
depression, bipolar disorder, transcranial stimulation, mixed states, episodes, randomized controlled (clinical) trial
URI
https://observatorio.fm.usp.br/handle/OPI/37655
Referências
  1. Angst J, 2011, ARCH GEN PSYCHIAT, V68, P791, DOI 10.1001/archgenpsychiatry.2011.87
  2. Association A, 2014, DSM 5 MAN DIAGN EST
  3. Azorin JM, 2012, J AFFECT DISORDERS, V143, P109, DOI 10.1016/j.jad.2012.05.036
  4. Benazzi F, 2001, PSYCHIAT RES, V103, P229, DOI 10.1016/S0165-1781(01)00258-X
  5. Berlim MT, 2014, PSYCHOL MED, V44, P225, DOI 10.1017/S0033291713000512
  6. Berlim MT, 2013, J CLIN PSYCHIAT, V74, pE122, DOI 10.4088/JCP.12r07996
  7. Bertschy G, 2007, BIPOLAR DISORD, V9, P907, DOI 10.1111/j.1399-5618.2007.00462.x
  8. Blumberger DM, 2018, LANCET, V391, P1683, DOI 10.1016/S0140-6736(18)30295-2
  9. Caliyurt O, 2017, BALK MED J, V34, P514, DOI 10.4274/balkanmedj.2017.1280
  10. Cao X, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00413
  11. Castelein S, 2014, Tijdschr Psychiatr, V56, P533
  12. Del-Ben Cristina Marta, 2001, Revista Brasileira de Psiquiatria, V23, P156, DOI 10.1590/S1516-44462001000300008
  13. Duarte-Guerra LS, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0823-8
  14. Fagiolini A, 2015, CNS DRUGS, V29, P725, DOI 10.1007/s40263-015-0275-6
  15. Giglio LMF, 2009, J AFFECT DISORDERS, V118, P161, DOI 10.1016/j.jad.2009.01.018
  16. Fernandez KC, 2016, COGNITIVE THER RES, V40, P426, DOI 10.1007/s10608-016-9772-2
  17. Fitzgerald PB, 2020, BRAIN STIMUL, V13, P137, DOI 10.1016/j.brs.2019.08.013
  18. Fitzgerald PB, 2018, NEUROPSYCHOPHARMACOL, V43, P1565, DOI 10.1038/s41386-018-0009-9
  19. Fleck MPA, 2000, REV SAUDE PUBL, V34, P178, DOI 10.1590/S0034-89102000000200012
  20. Freire Manoela Ávila, 2014, J. bras. psiquiatr., V63, P281, DOI 10.1590/0047-2085000000036
  21. Frye MA, 2009, AM J PSYCHIAT, V166, P164, DOI 10.1176/appi.ajp.2008.08030322
  22. Goldberg JF, 2009, AM J PSYCHIAT, V166, P173, DOI 10.1176/appi.ajp.2008.08050746
  23. Guy W., 1976, ASSESSMENT MANUAL PS, P341
  24. Hawley CJ, 2002, J AFFECT DISORDERS, V72, P177, DOI 10.1016/S0165-0327(01)00451-7
  25. Heale Roberta, 2015, Evid Based Nurs, V18, P66, DOI 10.1136/eb-2015-102129
  26. Hergueta T, 2013, INT J BIPOLAR DISORD, V1, DOI 10.1186/2194-7511-1-21
  27. Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379
  28. JONES SH, 1995, BRIT J PSYCHIAT, V166, P654, DOI 10.1192/bjp.166.5.654
  29. Jorge MR, 2002, MANUAL DIAGNOSTICO E
  30. Judd LL, 2012, J AFFECT DISORDERS, V138, P440, DOI 10.1016/j.jad.2011.12.046
  31. Kaladjian A, 2013, ENCEPHALE, V39, pS162, DOI 10.1016/S0013-7006(13)70116-7
  32. Kennedy SH, 2016, CAN J PSYCHIAT, V61, P540, DOI 10.1177/0706743716659417
  33. Kirkpatrick L, 2012, SIMPLE GUIDE IBM SPS
  34. Koukopoulos A, 2007, ACTA PSYCHIAT SCAND, V115, P50, DOI 10.1111/j.1600-0447.2007.00963.x
  35. Lefaucheur JP, 2020, CLIN NEUROPHYSIOL, V131, P474, DOI 10.1016/j.clinph.2019.11.002
  36. Li CT, 2018, BRAIN STIMUL, V11, P1054, DOI 10.1016/j.brs.2018.04.014
  37. Li CT, 2014, BRAIN, V137, P2088, DOI 10.1093/brain/awu109
  38. LINGJAERDE O, 1987, ACTA PSYCHIAT SCAND, V76, P7
  39. Malhi GS, 2016, J AFFECT DISORDERS, V192, P104, DOI 10.1016/j.jad.2015.12.009
  40. Malloy-Diniz Leandro Fernandes, 2010, J. bras. psiquiatr., V59, P99, DOI 10.1590/S0047-20852010000200004
  41. McIntyre RS, 2013, J AFFECT DISORDERS, V150, P378, DOI 10.1016/j.jad.2013.04.025
  42. McIntyre RS, 2015, J CLIN PSYCHIAT, V76, P398, DOI 10.4088/JCP.14m09410
  43. McIntyre RS, 2015, J AFFECT DISORDERS, V172, P259, DOI 10.1016/j.jad.2014.09.026
  44. Miller S, 2016, AM J PSYCHIAT, V173, P1015, DOI 10.1176/appi.ajp.2016.15091119
  45. Oberman L, 2011, J CLIN NEUROPHYSIOL, V28, P67, DOI 10.1097/WNP.0b013e318205135f
  46. Pae CU, 2012, J AFFECT DISORDERS, V136, P1059, DOI 10.1016/j.jad.2011.11.024
  47. Pallanti S, 2014, J AFFECT DISORDERS, V157, P66, DOI 10.1016/j.jad.2013.12.024
  48. Perugi G, 2015, J CLIN PSYCHIAT, V76, pE351, DOI 10.4088/JCP.14m09092
  49. Perugi G, 2014, COMPR PSYCHIAT, V55, P799, DOI 10.1016/j.comppsych.2014.01.012
  50. Piper BJ, 2015, PEERJ, V3, DOI 10.7717/peerj.1460
  51. Quante M, 2015, SLEEP HEALTH, V1, P275, DOI 10.1016/j.sleh.2015.09.002
  52. Rosenblat JD, 2017, CNS SPECTRUMS, V22, P147, DOI 10.1017/S1092852916000432
  53. Sayar GH, 2013, NEUROPSYCH DIS TREAT, V9, P501, DOI 10.2147/NDT.S44241
  54. Schneider W., 2002, E PRIME VERSION 2 0
  55. Schwippel T, 2019, PROG NEURO-PSYCHOPH, V92, P285, DOI 10.1016/j.pnpbp.2019.01.014
  56. Seo HJ, 2016, GEN HOSP PSYCHIAT, V39, P91, DOI 10.1016/j.genhosppsych.2015.12.005
  57. Shim IH, 2015, J AFFECT DISORDERS, V173, P120, DOI 10.1016/j.jad.2014.10.061
  58. Silva C. F., 2002, REV PSICOLOGIA EDUCA, V1, P39
  59. StataCorp L, 2007, SPECIAL EDITION RELE, V10, P733
  60. Swann AC, 2013, AM J PSYCHIAT, V170, P31, DOI 10.1176/appi.ajp.2012.12030301
  61. Swann AC, 2009, WORLD PSYCHIATRY, V8, P166
  62. Takeshima M, 2015, PSYCHIAT CLIN NEUROS, V69, P109, DOI 10.1111/pcn.12213
  63. Talih F, 2018, SLEEP MED REV, V41, P133, DOI 10.1016/j.smrv.2018.02.002
  64. Targum SD, 2016, PROG NEURO-PSYCHOPH, V68, P9, DOI 10.1016/j.pnpbp.2016.02.007
  65. Tavormina G, 2019, PSYCHIAT DANUB, V31, pS434
  66. Tavormina G, 2013, PSYCHIAT DANUB, V25, pS190
  67. Tazawa Y, 2019, J AFFECT DISORDERS, V253, P257, DOI 10.1016/j.jad.2019.04.087
  68. Tohen M, 2014, J AFFECT DISORDERS, V164, P57, DOI 10.1016/j.jad.2014.04.003
  69. Trede K, 2005, HARVARD REV PSYCHIAT, V13, P155, DOI 10.1080/10673220500174833
  70. Vanderhasselt MA, 2013, NEUROPSYCHOLOGIA, V51, P2581, DOI 10.1016/j.neuropsychologia.2013.08.011
  71. Vazquez GH, 2018, J AFFECT DISORDERS, V225, P756, DOI 10.1016/j.jad.2017.09.006
  72. Verdolini Norma, 2015, ScientificWorldJournal, V2015, P757258, DOI 10.1155/2015/757258
  73. Vilela JAA, 2005, BRAZ J MED BIOL RES, V38, P1429, DOI 10.1590/S0100-879X2005000900019
  74. West B. T., 2014, LINEAR MIXED MODELS
  75. Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955
  76. Yatham LN, 2013, BIPOLAR DISORD, V15, P1, DOI 10.1111/bdi.12025

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - LIM/27